Assessment of In-Hospital Mortality and Its Risk Factors in Patients with Myocardial Infarction Considering the Logistical Aspects of the Treatment Process—A Single-Center, Retrospective, Observational Study
暂无分享,去创建一个
[1] Lukasz Gawinski,et al. Practical Aspects of the Use of Telematic Systems in the Diagnosis of Acute Coronary Syndrome in Poland , 2022, Medicina.
[2] G. Sinagra,et al. [ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: what's new?] , 2022, Giornale italiano di cardiologia.
[3] Xiao-Ce Dai,et al. Association Between Out-of-Hour Admission and Short- and Long-Term Mortality in Acute Myocardial Infarction: A Systematic Review and Meta-Analysis , 2021, Frontiers in Cardiovascular Medicine.
[4] P. Engelseth,et al. Application of Modern Clinical Risk Scores in the Global Assessment of Risks Related to the Diagnosis and Treatment of Acute Coronary Syndromes in Everyday Medical Practice , 2021, International journal of environmental research and public health.
[5] J. McMurray,et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. , 2021, European heart journal.
[6] Yan Li,et al. The Clinical and Angiographic Outcomes of Postdilation after Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome: A Systematic Review and Meta-Analysis , 2021, Journal of interventional cardiology.
[7] F. Gragnano,et al. Myocardial Infarction with and without ST-segment Elevation: a Contemporary Reappraisal of Similarities and Differences , 2020, Current cardiology reviews.
[8] Lukasz Gawinski,et al. Telematic Support of Management Processes in Diagnosis and Treatment of Acute Myocardial Infarction in Poland , 2020 .
[9] Lukasz Gawinski,et al. Management of Processes of the Diagnosis and Treatment of Acute Myocardial Infarction Using Telematics Systems , 2020 .
[10] Deepak L. Bhatt,et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. , 2020, European heart journal.
[11] M. Salarifar,et al. Short‐term safety and long‐term benefits of stent postdilation after primary percutaneous coronary intervention: Results of a cohort study , 2020, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[12] Umesh M Pai,et al. In-stent restenosis of drug-eluting stents: clinical presentation and outcomes in a real-world scenario , 2019, The Egyptian Heart Journal.
[13] K. Fox,et al. Association between time of hospitalization with acute myocardial infarction and in-hospital mortality , 2019, European heart journal.
[14] Eric J Velazquez,et al. Guidelines for Performing a Comprehensive Transthoracic Echocardiographic Examination in Adults: Recommendations from the American Society of Echocardiography. , 2019, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[15] Volkmar Falk,et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. , 2018, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[16] Kristian Thygesen,et al. Fourth Universal Definition of Myocardial Infarction (2018). , 2018, Journal of the American College of Cardiology.
[17] E. Bramucci,et al. Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial , 2018, The Lancet.
[18] P. Armstrong,et al. Population-level incidence and outcomes of myocardial infarction with non-obstructive coronary arteries (MINOCA): Insights from the Alberta contemporary acute coronary syndrome patients invasive treatment strategies (COAPT) study. , 2018, International journal of cardiology.
[19] Panos Vardas,et al. European Society of Cardiology: Cardiovascular Disease Statistics 2017. , 2018, European heart journal.
[20] Marco Valgimigli,et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). , 2018, European heart journal.
[21] Sunil V. Rao,et al. Outcomes of PCI in Relation to Procedural Characteristics and Operator Volumes in the United States. , 2017, Journal of the American College of Cardiology.
[22] R. Cruz Ferreira,et al. ProACS risk score: An early and simple score for risk stratification of patients with acute coronary syndromes. , 2017, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.
[23] R. Kiss,et al. A novel risk model including vascular access site for predicting 30-day mortality after primary PCI: The ALPHA score. , 2017, Cardiovascular revascularization medicine : including molecular interventions.
[24] Sunil V. Rao,et al. Radial Versus Femoral Access for Coronary Interventions Across the Entire Spectrum of Patients With Coronary Artery Disease: A Meta-Analysis of Randomized Trials. , 2016, JACC. Cardiovascular interventions.
[25] J. Shalhoub,et al. Trends in Mortality From Ischemic Heart Disease and Cerebrovascular Disease in Europe: 1980 to 2009 , 2016, Circulation.
[26] Baris Gencer,et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation , 2011 .
[27] E. Braunwald. The ten advances that have defined modern cardiology. , 2014, Trends in cardiovascular medicine.
[28] G. Stone,et al. Coronary artery calcification: pathogenesis and prognostic implications. , 2014, Journal of the American College of Cardiology.
[29] G. Stone,et al. Incidence and predictors of coronary stent thrombosis: evidence from an international collaborative meta-analysis including 30 studies, 221,066 patients, and 4276 thromboses. , 2013, International journal of cardiology.
[30] M. Matheny,et al. Risk‐Treatment Paradox in the Selection of Transradial Access for Percutaneous Coronary Intervention , 2013, Journal of the American Heart Association.
[31] S. Kurz,et al. Introduction of high-sensitivity troponin assays: impact on myocardial infarction incidence and prognosis. , 2012, The American journal of medicine.
[32] A. Alsheikh-Ali,et al. Impact of Anemia on In-Hospital, One-Month and One-Year Mortality in Patients with Acute Coronary Syndrome from the Middle East , 2012, Clinical Medicine & Research.
[33] Helmut Baumgartner,et al. ESC / EACTS Guidelines on myocardial revascularization , 2014 .
[34] P. Serruys,et al. EuroHeart score for the evaluation of in-hospital mortality in patients undergoing percutaneous coronary intervention. , 2011, European heart journal.
[35] C. Terkelsen,et al. System delay and mortality among patients with STEMI treated with primary percutaneous coronary intervention. , 2010, JAMA.
[36] Claes Held,et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. , 2009, The New England journal of medicine.
[37] F. Verheugt,et al. Predictors of coronary stent thrombosis: the Dutch Stent Thrombosis Registry. , 2009, Journal of the American College of Cardiology.
[38] Adnan Kastrati,et al. Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis. , 2009, Journal of the American College of Cardiology.
[39] E. Antman,et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. , 2007, The New England journal of medicine.
[40] P. Serruys,et al. Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions , 2007, Circulation.
[41] R. Kornowski,et al. The impact of circadian variation on outcomes in emergency acute anterior myocardial infarction percutaneous coronary intervention , 2006, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[42] J. Ottervanger,et al. Circadian variation in myocardial perfusion and mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty. , 2005, American heart journal.
[43] T. Brennan,et al. Incidence of adverse events and negligence in hospitalized patients: results of the Harvard Medical Practice Study I* , 2004, Quality and Safety in Health Care.
[44] Á. Avezum,et al. Predictors of hospital mortality in the global registry of acute coronary events. , 2003, Archives of internal medicine.
[45] H. Gerstein,et al. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview , 2000, The Lancet.
[46] A. Levey,et al. A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.
[47] M. Funk,et al. Predicting hospital mortality in patients with acute myocardial infarction. , 1994, American journal of critical care : an official publication, American Association of Critical-Care Nurses.
[48] A. Albert,et al. Short‐term risk stratification at admission based on simple clinical data in acute myocardial infarction , 1989, The American journal of cardiology.
[49] H. S. Mueller,et al. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. , 1985, The New England journal of medicine.
[50] P. Brandt,et al. A new coronary prognostic index. , 1969, American heart journal.
[51] T. Killip,et al. Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. , 1967, The American journal of cardiology.